These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 29109949)
1. The Impact of Frailty on the Risk of Conversion from Mild Cognitive Impairment to Alzheimer's Disease: Evidences from a 5-Year Observational Study. Trebbastoni A; Canevelli M; D'Antonio F; Imbriano L; Podda L; Rendace L; Campanelli A; Celano V; Bruno G; de Lena C Front Med (Lausanne); 2017; 4():178. PubMed ID: 29109949 [TBL] [Abstract][Full Text] [Related]
2. Prospective longitudinal study of frailty transitions in a community-dwelling cohort of older adults with cognitive impairment. Chong MS; Tay L; Chan M; Lim WS; Ye R; Tan EK; Ding YY BMC Geriatr; 2015 Dec; 15():175. PubMed ID: 26715536 [TBL] [Abstract][Full Text] [Related]
3. Conversion of mild cognitive impairment to dementia in elderly subjects: a preliminary study in a memory and cognitive disorder unit. Maioli F; Coveri M; Pagni P; Chiandetti C; Marchetti C; Ciarrocchi R; Ruggero C; Nativio V; Onesti A; D'Anastasio C; Pedone V Arch Gerontol Geriatr; 2007; 44 Suppl 1():233-41. PubMed ID: 17317458 [TBL] [Abstract][Full Text] [Related]
4. Frailty in randomised controlled trials for dementia or mild cognitive impairment measured via the frailty index: prevalence and prediction of serious adverse events and attrition. Wightman H; Quinn TJ; Mair FS; Lewsey J; McAllister DA; Hanlon P Alzheimers Res Ther; 2023 Jun; 15(1):110. PubMed ID: 37312157 [TBL] [Abstract][Full Text] [Related]
5. Anosognosia Is an Independent Predictor of Conversion From Mild Cognitive Impairment to Alzheimer's Disease and Is Associated With Reduced Brain Metabolism. Gerretsen P; Chung JK; Shah P; Plitman E; Iwata Y; Caravaggio F; Nakajima S; Pollock BG; Graff-Guerrero A; J Clin Psychiatry; 2017; 78(9):e1187-e1196. PubMed ID: 29022655 [TBL] [Abstract][Full Text] [Related]
6. Association Between Olfactory Dysfunction and Amnestic Mild Cognitive Impairment and Alzheimer Disease Dementia. Roberts RO; Christianson TJ; Kremers WK; Mielke MM; Machulda MM; Vassilaki M; Alhurani RE; Geda YE; Knopman DS; Petersen RC JAMA Neurol; 2016 Jan; 73(1):93-101. PubMed ID: 26569387 [TBL] [Abstract][Full Text] [Related]
7. Increased Serum miR-206 Level Predicts Conversion from Amnestic Mild Cognitive Impairment to Alzheimer's Disease: A 5-Year Follow-up Study. Xie B; Liu Z; Jiang L; Liu W; Song M; Zhang Q; Zhang R; Cui D; Wang X; Xu S J Alzheimers Dis; 2017; 55(2):509-520. PubMed ID: 27662297 [TBL] [Abstract][Full Text] [Related]
8. A longitudinal follow-up of 550 mild cognitive impairment patients: evidence for large conversion to dementia rates and detection of major risk factors involved. Espinosa A; Alegret M; Valero S; Vinyes-Junqué G; Hernández I; Mauleón A; Rosende-Roca M; Ruiz A; López O; Tárraga L; Boada M J Alzheimers Dis; 2013; 34(3):769-80. PubMed ID: 23271318 [TBL] [Abstract][Full Text] [Related]
9. Frailty Index and Cognitive Decline in Alzheimer's Disease: Data from the Impact of Cholinergic Treatment USe Study. Kelaiditi E; Canevelli M; Andrieu S; Del Campo N; Soto ME; Vellas B; Cesari M; J Am Geriatr Soc; 2016 Jun; 64(6):1165-70. PubMed ID: 27321595 [TBL] [Abstract][Full Text] [Related]
10. Targeting Cognitive Frailty: Clinical and Neurobiological Roadmap for a Single Complex Phenotype. Panza F; Seripa D; Solfrizzi V; Tortelli R; Greco A; Pilotto A; Logroscino G J Alzheimers Dis; 2015; 47(4):793-813. PubMed ID: 26401761 [TBL] [Abstract][Full Text] [Related]
11. Impact of Depressive Symptoms on Conversion from Mild Cognitive Impairment Subtypes to Alzheimer's Disease: A Community-Based Longitudinal Study. Kida J; Nemoto K; Ikejima C; Bun S; Kakuma T; Mizukami K; Asada T J Alzheimers Dis; 2016; 51(2):405-15. PubMed ID: 26890740 [TBL] [Abstract][Full Text] [Related]
12. Erlangen Score as a tool to predict progression from mild cognitive impairment to dementia in Alzheimer's disease. Baldeiras I; Santana I; Leitão MJ; Vieira D; Duro D; Mroczko B; Kornhuber J; Lewczuk P Alzheimers Res Ther; 2019 Jan; 11(1):2. PubMed ID: 30611311 [TBL] [Abstract][Full Text] [Related]
13. Magnetic resonance imaging white matter hyperintensities and brain volume in the prediction of mild cognitive impairment and dementia. Smith EE; Egorova S; Blacker D; Killiany RJ; Muzikansky A; Dickerson BC; Tanzi RE; Albert MS; Greenberg SM; Guttmann CR Arch Neurol; 2008 Jan; 65(1):94-100. PubMed ID: 18195145 [TBL] [Abstract][Full Text] [Related]
14. Memory performance on the story recall test and prediction of cognitive dysfunction progression in mild cognitive impairment and Alzheimer's dementia. Park JH; Park H; Sohn SW; Kim S; Park KW Geriatr Gerontol Int; 2017 Oct; 17(10):1603-1609. PubMed ID: 27910252 [TBL] [Abstract][Full Text] [Related]
15. Olfactory function and neuropsychological profile to differentiate dementia with Lewy bodies from Alzheimer's disease in patients with mild cognitive impairment: A 5-year follow-up study. Yoon JH; Kim M; Moon SY; Yong SW; Hong JM J Neurol Sci; 2015 Aug; 355(1-2):174-9. PubMed ID: 26076880 [TBL] [Abstract][Full Text] [Related]
16. Proton Pump Inhibitors and Risk of Mild Cognitive Impairment and Dementia. Goldstein FC; Steenland K; Zhao L; Wharton W; Levey AI; Hajjar I J Am Geriatr Soc; 2017 Sep; 65(9):1969-1974. PubMed ID: 28590010 [TBL] [Abstract][Full Text] [Related]
17. Framingham Risk Score and the Risk of Progression from Mild Cognitive Impairment to Dementia. Viticchi G; Falsetti L; Buratti L; Sajeva G; Luzzi S; Bartolini M; Provinciali L; Silvestrini M J Alzheimers Dis; 2017; 59(1):67-75. PubMed ID: 28582863 [TBL] [Abstract][Full Text] [Related]
18. Frailty Index and Incident Mortality, Hospitalization, and Institutionalization in Alzheimer's Disease: Data From the ICTUS Study. Kelaiditi E; Andrieu S; Cantet C; Vellas B; Cesari M; J Gerontol A Biol Sci Med Sci; 2016 Apr; 71(4):543-8. PubMed ID: 26273022 [TBL] [Abstract][Full Text] [Related]